AzTrials
AzTrials

Skin Graft DetachmentNCT05831020

Method of Securing Skin Graft: A Comparison of Vacuum Assisted Closure Device Versus Bolster Dressing

A study testing VAC and bolster dressing in people with Skin Graft Detachment, run by Dow University of Health Sciences at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this randomized controlled trial is to compare the outcomes of vacuum assisted closure device versus conventional bolster dressing in securing split thickness skin graft in traumatic wounds; with emphasis on percentage of graft take and postoperative complications like hematoma, seroma and infection of… Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Skin Graft Detachment
What is being tested?
VAC and bolster dressing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
1 sitePakistan
Study dates
21 Oct 2021to 20 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • All patients undergoing skin graft at the Civil Hospital
  • aged 18 years to 60 years
  • either gender
  • ASA grade 1
  • Traumatic wounds of size 25 cm2 to 225 cm2 and of greater than 14 days duration with healthy granulation tissue and
  • Consenting to participate in the study.

Who cannot join

  • Patients with signs of wound infection
  • Patients with wounds of poor blood supply
  • Patients known for allergy or sensitivity to acrylic adhesives.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Dow University of Health Sciences

    Karachi, 7

Other trials in Pakistan

About this study

The goal of this randomized controlled trial is to compare the outcomes of vacuum assisted closure device versus conventional bolster dressing in securing split thickness skin graft in traumatic wounds; with emphasis on percentage of graft take and postoperative complications like hematoma, seroma and infection of graft site. Two groups were formed with 70 patients in each group. Patients were randomly allocated either to group A(VAC group) or group B(bolster dressing group) and outcomes were assessed on 5th post-operative day when first dressing change was done

Read the detailed description

This randomized controlled trial was conducted at the Department of Plastic and Reconstructive Surgery at Dr. Ruth K.M. Pfau Civil Hospital Karachi from 21st October 2021 to 20th June 2022. Before conducting the study, ethical approval was obtained from Dow University of Health Sciences (DUHS) (IRB-2125/DUHS/Approval/2021/637).

All patients were enrolled via non-probability consecutive sampling. The sample size for the current study was calculated as follows:

Mean graft take for VAC group = 96 ±6 Mean graft take for conventionally treated group = 89±20 (10) Level of confidence = 95% Power = 80% A sample of 140 patients (70 per group) was required to detect mean difference of 7 in graft take between two groups as estimated by using the above parameters through online available calculator Open Epi.

Patients visiting outpatient department and requiring skin graft were admitted to Plastic surgery and recruited into the study with their consent. Study purpose and risk and benefits associated with the procedure were explained to the patient to obtain their consent. Total 70 patients in each group, meeting the inclusion criteria were enrolled. Patients were randomly allocated either to the conventional group or new technique group. Random allocation of patients was done using the SNOSE (sequentially numbered opaque sealed envelope) protocol. Total 140 sequentially numbered opaque sealed envelopes was prepared enclosing the group name with half of the envelop will be enclosing name of group A (VAC group) and other half enclosing the group b (bolster dressing group) and after that envelops was shuffled to ensure randomization.

Skin grafting was performed under general anesthesia. Humby's knife was used to harvest skin graft from donor site. Skin graft was hand meshed and secured to the recipient site circumferentially with absorbable sutures, followed by Tincture of benzoin soaked paraffin gauze layer. For the bolster dressing group, the recipient site was bolstered with wet bulky cotton gauze dressing and wrapped with cotton bandage. 0.9% normal saline was used for moisture. For the Vacuum assisted closure (VAC) Group, two sheets of sterilized VAC sponge that was cut to fit the wound contour were placed with a fenestrated tube between the two layers that was secured to the surrounding skin using tincture of benzoin spray and an adhesive dressing (OPSITE). The VAC was placed at -125mmHg suction and checked for any air leak. Any loss of suction was treated by reinforcing the adhesive dressing over the air leak. The VAC was decompressed and clamped till the patient is shifted back to the ward. Once in ward, The VAC was placed to intermittent -125 mmHg suction for 2 hours and then decompressed for next 2 hours. Bed rest, sling or splint was used for immobilization depending on the location of injury.

Patients were permitted for slight movement for personal hygiene reasons. First dressing change was done on 5th post-operative day. They underwent early change of dressing in case excessive soakage of dressing with blood, serous fluid or foul smelling discharge or pus was present. Dressing of patient was opened on 5th operative day by researcher and then assessed by supervising consultant for percentage of skin graft take and post-operative complications. A pre-designed proforma was designed to collect the data. Patients' data was kept confidential. Medical record no. of patients was tagged with other serial number to assure the confidentiality of the data and only principal investigator had an access to original data.

Data was entered and analyzed by using SPSS version 21. Qualitative variables like gender, socioeconomic status, place of residence, smoking status, medical comorbidities (such as diabetes mellitus and hypertension), graft site, donor site, post-operative complications were presented as frequency with percentages. Quantitative variables such as age, height, weight, BMI, graft size, length of stay in the hospital, percentage of graft take were summarized in terms of mean standard deviation. Effect-modifiers such as age, gender, BMI, smoking status, graft site, graft size, diabetes and hypertension will be controlled through stratification. Post-stratification independent t-test or Mann Whitney U test will be applied to compare percentage of graft take among two treatment groups. Post-stratification chi-square test will be applied to assess difference of post-operative complications among two treatment groups. P-value <0.05 was considered as statistically significant.

Being tested
VAC and bolster dressing
Keywords
Graft take, vacuum assisted, Bolster dressing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VAC and bolster dressingOther

    Bolster dressing- Moist bulky cotton gauze dressing and wrapped with cotton bandage.

    Vacuum assisted closure (VAC) dressing- A fenestrated tube placed between two sheets of sterilized foam secured to the surrounding skin using adhesive dressing (OPSITE).

Study groups in NCT05831020
Study groupRoleWhat they receive
Group A (VAC group)Active comparatorFor Group A, VAC dressing was placed to secure split thickness skin graft. Two sheets of sterilized VAC sponge that was cut to fit the wound contour were placed with a fenestrated tube between the two layers that was secured to the surrounding skin using tincture of benzoin spray and an adhesive dressing (OPSITE). The VAC was placed to intermittent -125 mmHg suction for 2 hours and then decompressed for next 2 hours.
Receives: Other: VAC and bolster dressing
Group B (Bolster dressing group)Active comparatorFor Group B, Bolster dressing was done to secure split thickness skin graft. The recipient site was bolstered with wet bulky cotton gauze dressing and wrapped with cotton bandage. 0.9% normal saline was used for moisture.
Receives: Other: VAC and bolster dressing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Graft take

    Defined as the percentage of the skin graft which is adherent to the recipient wound which is wound size. The area for wound size will be pre-operatively measured using ruler in centimeter square and the area where graft is adherent will be measured in percentage. It will be visually assessed by consultant surgeon at the time of first dressing change

    Measured: 5th post-operative day or earlier if excessive soakage of dressing

Secondary outcomes (1)
  1. Post-operative complications

    Hematoma, seroma and wound infection will be assessed visually by the consultant surgeon on first dressing change.

    Measured: 5th post-operative day or earlier if excessive soakage of dressing

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Apr 2023
  2. Study start21 Oct 2021
  3. Primary completion20 Jun 2022
  4. Study completion20 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A two arm parallel assignment, where group A will be VAC group and group B will be bolster dressing group.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
140 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05831020
Sponsor's protocol ID
IRB2125/DUHS/Approval/2021/637
Status last verified
Apr 2023
First submitted
14 Apr 2023
Last updated
26 Apr 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: To maintain confidentiality of participants, medical record no. of patients was tagged with other serial number and only principal investigator had and will have an access to original data.

Publications

  • Mohsin M, Zargar HR, Wani AH, Zaroo MI, Baba PUF, Bashir SA, Rasool A, Bijli AH. Role of customised negative-pressure wound therapy in the integration of split-thickness skin grafts: A randomised control study. Indian J Plast Surg. 2017 Jan-Apr;50(1):43-49. doi: 10.4103/ijps.IJPS_196_16.

    PubMed 28615809
  • Scherer LA, Shiver S, Chang M, Meredith JW, Owings JT. The vacuum assisted closure device: a method of securing skin grafts and improving graft survival. Arch Surg. 2002 Aug;137(8):930-3; discussion 933-4. doi: 10.1001/archsurg.137.8.930.

    PubMed 12146992
  • Lee SH, Kim YJ. Effectiveness of double tie-over dressing compared with bolster dressing. Arch Plast Surg. 2018 May;45(3):266-270. doi: 10.5999/aps.2017.01424. Epub 2018 May 15.

    PubMed 29788688
  • Dhillon M, Carter CP, Morrison J, Hislop WS, Currie WJ. A comparison of skin graft success in the head & neck with and without the use of a pressure dressing. J Maxillofac Oral Surg. 2015 Jun;14(2):240-2. doi: 10.1007/s12663-014-0618-8. Epub 2014 Feb 11.

    PubMed 26028841
  • Azzopardi EA, Boyce DE, Dickson WA, Azzopardi E, Laing JH, Whitaker IS, Shokrollahi K. Application of topical negative pressure (vacuum-assisted closure) to split-thickness skin grafts: a structured evidence-based review. Ann Plast Surg. 2013 Jan;70(1):23-9. doi: 10.1097/SAP.0b013e31826eab9e.

    PubMed 23249474
  • Kucharzewski M, Mieszczanski P, Wilemska-Kucharzewska K, Taradaj J, Kuropatnicki A, Sliwinski Z. The application of negative pressure wound therapy in the treatment of chronic venous leg ulceration: authors experience. Biomed Res Int. 2014;2014:297230. doi: 10.1155/2014/297230. Epub 2014 Feb 18.

    PubMed 24696847
  • Yadav S, Rawal G, Baxi M. Vacuum assisted closure technique: a short review. Pan Afr Med J. 2017 Nov 21;28:246. doi: 10.11604/pamj.2017.28.246.9606. eCollection 2017.

    PubMed 29881491

Questions about this trial

What is this clinical trial studying?

A study testing VAC and bolster dressing in people with Skin Graft Detachment, run by Dow University of Health Sciences at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Graft take (time frame: 5th post-operative day or earlier if excessive soakage of dressing). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05831020, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in